Planisware SA: Recent Transactions on Own Shares
Planisware SA, a provider of strategic portfolio management cloud solutions, has disclosed its recent transactions involving its own shares for the periods covering early October 2025. The company is listed on the NYSE Euronext Paris under the ticker PLNW and has a market capitalization of approximately 1.38 billion EUR.
1. Transaction Summary (29 September – 3 October 2025)
| Date | Market (MIC) | Shares Purchased | Purchase Price (€) |
|---|---|---|---|
| 29 Sep 2025 | XPAR | 14,100 | 19.3900 |
| 30 Sep 2025 | XPAR | 14,700 | 19.6700 |
| 01 Oct 2025 | XPAR | 14,400 | 19.5800 |
| 02 Oct 2025 | XPAR | 14,600 | 19.9400 |
| 03 Oct 2025 | XPAR | 14,800 | 19.8900 |
| Total | 72,600 | 19.6969 |
The aggregate volume of 72,600 shares was acquired at a daily weighted average price of 19.70 EUR. All purchases were executed on the Paris exchange (XPAR) under the MIC code XPAR.
2. Transaction Summary (6 October – 10 October 2025)
A second statement, filed on 16 October 2025, reports transactions for the period 6 October – 10 October 2025. Although specific trade details for this window are not itemized in the available excerpt, the filing confirms that the company continued to engage in own‑share transactions during this timeframe.
3. Context and Regulatory Framework
Under French securities regulations, public‑listed companies must disclose any purchase or sale of their own shares within 10 days of the transaction. These statements are published through the e‑Registre system and are publicly accessible, ensuring transparency for investors.
4. Relevance to Investors
- Share Price Impact: The average purchase price of 19.70 EUR is slightly above the current closing price of 19.70 EUR (as of 13 October 2025), suggesting a modest upward pressure on the share value during the reporting period.
- Market Activity: The consistent daily volume indicates active management of share capital, which may reflect the company’s confidence in its valuation or strategic capital structure adjustments.
- Financial Health: With a 52‑week high of 29.99 EUR and a 52‑week low of 17.40 EUR, the recent transactions occur near the lower end of the band, potentially positioning the company to benefit from future price appreciation.
5. Summary
Planisware SA has maintained a steady pattern of purchasing its own shares over the first week of October 2025, acquiring a total of 72,600 shares at an average price close to its prevailing market value. The company’s disclosure of these transactions aligns with regulatory requirements and provides investors with insight into its capital management strategy.
